Mo Xiaoyan, Wu Yuanyuan, Chen Li, Zhai Ming, Gao Zhengdong, Hu Kainan, Guo Junming
Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Medical School of Ningbo University, Ningbo, China.
J Clin Lab Anal. 2019 Feb;33(2):e22692. doi: 10.1002/jcla.22692. Epub 2018 Oct 15.
Long noncoding RNAs (lncRNAs) have roles in regulating metabolism; however, the global expression profile of metabolic pathway-associated lncRNAs in gastric cancer is unknown. The purpose of our study was to examine metabolic pathway-related lncRNAs in gastric cancer and their possible diagnostic values.
Differential expression patterns of metabolic pathway-related lncRNAs between gastric cancer and paired nontumor tissues were detected using metabolic pathway-associated lncRNA microarrays. The expression of RP11-555H23.1, one representative metabolic pathway-associated lncRNA, was validated using quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR). The associations between RP11-55H23.1 expression and the clinicopathological features of gastric cancer patients were analyzed. A receiver operating characteristic (ROC) curve was further established.
A total of 114 differentially expressed metabolic pathway-associated lncRNAs (fold change >2, P < 0.05) between cancer and nontumor tissues were found (GEO No. GSE96856). Among them, TUG1, RP11-555H23.1, RP1-257I20.13, UGP2, GCSHP3, and XLOC_000889 lncRNAs were downregulated more than sixfold in gastric cancer tissues. In contrast, RP11-605F14.2, TBC1D3P5, BC130595, LINC00475, RP11-19P22.6, BC080653, XLOC_004923, AFAP1-AS1, EPB49, and RP11-296I10.3 lncRNAs were upregulated more than sixfold in gastric cancer tissues. We further demonstrated that RP11-555H23.1 expression was significantly correlated with TNM stage (P = 0.038). The area under the ROC curve (AUC) was 0.65, and the specificity and sensitivity were 62% and 81%, respectively.
Metabolic pathway-associated lncRNAs play an important role in the occurrence of gastric cancer, and metabolic pathway-associated lncRNAs, such as RP11-555H23.1, may represent novel biomarkers of gastric cancer.
长链非编码RNA(lncRNA)在调节代谢中发挥作用;然而,胃癌中代谢途径相关lncRNA的整体表达谱尚不清楚。我们研究的目的是检测胃癌中与代谢途径相关的lncRNA及其可能的诊断价值。
使用代谢途径相关lncRNA微阵列检测胃癌组织与配对的非肿瘤组织之间代谢途径相关lncRNA的差异表达模式。使用定量实时逆转录-聚合酶链反应(qRT-PCR)验证一种代表性的代谢途径相关lncRNA即RP11-555H23.1的表达。分析RP11-55H23.1表达与胃癌患者临床病理特征之间的关联。进一步绘制受试者工作特征(ROC)曲线。
在癌组织与非肿瘤组织之间共发现114种差异表达的代谢途径相关lncRNA(倍数变化>2,P<0.05)(GEO编号GSE96856)。其中,TUG1、RP11-555H23.1、RP1-257I20.13、UGP2、GCSHP3和XLOC_000889 lncRNA在胃癌组织中下调超过6倍。相反,RP11-605F14.2、TBC1D3P5、BC130595、LINC00475、RP11-19P22.6、BC080653、XLOC_004923、AFAP1-AS1、EPB49和RP11-296I10.3 lncRNA在胃癌组织中上调超过6倍。我们进一步证明RP11-555H23.1表达与TNM分期显著相关(P = 0.038)。ROC曲线下面积(AUC)为0.65,特异性和敏感性分别为62%和81%。
代谢途径相关lncRNA在胃癌发生中起重要作用,并且代谢途径相关lncRNA,如RP11-555H23.1,可能代表胃癌的新型生物标志物。